| 
Results for novartis. Search took 0.30 seconds.
OTC Prevacid®, Heartburn Medicine Now FDA-Approved
in Straightfromthedoc, on May 15, 2009
...medications based on fewer office visits.
Prevacid and Prevacid 24Hr OTC are both products of Novartis .
...
MIT Sloan BioInnovations Conference
in Straightfromthedoc, on March 5, 2009
... following:
Naseem Amin, M.D. PhD; SVP, Business Development, Biogen Idec
Andrin Oswald, M.D.; CEO, Novartis Vaccines
Panels will include:
Entrepreneurship: Making Your Company a Success
Lesa Mitche...
Osteoporosis Drug Zometa Shrinks Breast Cancer Tumors
in Straightfromthedoc, on December 12, 2008
... Photo courtesy of iStockphoto , Eric Hood
The osteoporosis drug Zometa (a product of Novartis AG) has been found to shrink breast cancer tumors better than chemotherapy alone .
Zometa is cur...
FASB has drug makers squealing
in Sox First, on August 15, 2008
...their letter to the FASB, Pfizer Inc., Merck & Co., Eli Lilly & Co., Johnson & Johnson, Novartis AG, and WYETH are reported saying the estimates would be ""highly subjectiv...
2008-2009 Flu Vaccines, Approved By The FDA
in Straightfromthedoc, on August 10, 2008
...uLaval by ID Biomedical Corporation of Quebec
FluMist by MedImmune Vaccines Inc.
Fluvirin by Novartis Vaccines and Diagnostics Limited
Fluzone by Sanofi Pasteur Inc.
This season's va...
财富杂志公布 2008 全球 500 强
in Wangtam, on July 10, 2008
美国《财富》杂志 昨日公布 了 2008 年全球 500 强排行榜，沃尔玛以 3787.99 亿美元年销售额蝉联榜首，中石化排名第 16 位。
按照 2007 年销售额排名，排名前十的企业依次是：沃尔玛、美国埃克森美孚石油公司、英荷壳牌石油公司、英国石油公司、丰田汽车公司、美国雪佛龙石油公司、荷兰国际集团、法国道达尔石油公司、美国通用汽车公司和美国康菲石油公司。
中国内地和香港上榜企业从去年的 24 家增至 29 家，其中中石化以 1592.6 亿美元的年销售额排名第 16 位，成为排名最靠前的中国企业。
Novartis Diabetes Drug Eucreas, EU-Approved
in Daily Diabetic, on February 25, 2008
...The Novartis diabetes pill Eucreas has been approved by The European Union for type 2 diabetes . Eucreas is a combination of Galvus (a DPP-4 inhibitor) and metformin (a popular diabetes drug whic...
Targeting p110delta Protein to Treat Asthma and Allergies
in Allergies, on February 16, 2008
...this protein can block allergic reactions even before symptoms occur.
More recently, Genentech and Novartis AG have introduced a new medicine for severe asthma called Xolair that blocks a immune syst...
Takeda Filed for US Approval of Diabetes Drug Alogliptin
in Daily Diabetic, on January 4, 2008
... regulating blood glucose levels, and the class also includes Merck & Co's Januvia and Novartis AG 's Galvus ]
According to Takeda spokesman Toshiyuki Ikeuchi:
"We are hoping...
Börsenausblick 2008: Die Sonne scheint auf günstige Aktien
in Das Börsen Weblog, on January 1, 2008
Börse ARD ist aus meiner Sicht das beste Börsenportal für Anleger im Internet. Die Spezialisten haben auch für das nächste Jahre wieder einiges für Investoren zusammengestellt. Die wichtigsten Auszüge daraus kommen nun. Lohnend ist es für mich auch, immer mal wieder den Börsenaufsager vor...
Gleevec®, Proven Safe and Effective Over The Long Term
in Straightfromthedoc, on November 13, 2007
...ge survival was about three to four years."
Gleevec® (imatinib mesylate) - a product of Novartis - when first approved for CML has since been the standard of care for the disease.
Find mor...
Tasigna (nilotinib), FDA-Approved for Philadelphia Chromosome Positive CML
in Straightfromthedoc, on October 30, 2007
... Novartis Pharma 's Tasigna (nilotinib) has recently been approved by the US FDA for the treatment of Philadelphia chromosome positive chronic myeloid leukemia (CML) in adult patients whos...
Weltweit erste Produktionsanlage fuer Grippeimpfstoff aus Zellkulturen eroeffnet
in Das Gesundheits-Weblog, on October 5, 2007
...lassung für den europäischen Markt
erhalten.
Weitere Infos auf der Seite von Novartis .
...
Novartis Diabetes Drug Galvus, EU-Approved for Type 2 Diabetes
in Daily Diabetic, on October 1, 2007
...While Novartis AG is still waiting the FDA approval for its type 2 diabetes drug Galvus , the EU has already granted marketing approval for the said drug.
Galvus (vildagliptin) is a on...
Lamisil, FDA-Approved for Pediatric Treatment of Scalp Ringworm
in Straightfromthedoc, on September 30, 2007
...usually does not respond to topical treatment.
The FDA, in a pediatric written request, approached Novartis Pharmaceuticals Corporation of East Hanover, N.J., the manufacturer of Lamisil (terbinafine...
Galvus-Metformin Combo Works Better than Metformin Alone
in Daily Diabetic, on September 22, 2007
...vildagliptin .
According to Dr Sylvia Dejager, a principal medical and scientific officer at Novartis, USA who presented at the 43rd annual meeting of the European Association for the Study ...
How to develop a whistleblower culture
in Sox First, on September 11, 2007
...any with operations around the world? Ethical Corporation cites the case of pharmaceutical company Novartis which has "integrity lines" in 61 languages. Should the hotlines be anonymous? ...
FDA Approves Akorn's Generic Ketotifen Fumarate Ophthalmic Solution, 0.025%
in Allergies, on July 29, 2007
...use of Akorn 's Ketotifen Fumarate Ophthalmic Solution, 0.025% - the generic version of Novartis ' Zaditor™Ophthalmic Solution 0.025% .
Zaditor™ Ophthalmic Solution 0.025% (recently ...
Aliskiren-Valsartan Combo, Better at Lowering Blood Pressure
in Straightfromthedoc, on July 25, 2007
...nder the brand name Tekturna® while valsartan under the brand name Diovan® , both products of Novartis .
Find more details from the full report ....
Nestle Took-over Novartis Medical Nutrition for US$2.5bn
in The Biotech Weblog, on July 5, 2007
... After a long-awaited deal, Nestle has confirmed its successful take-over of Novartis Medical Nutrition to the tune of US$2.5bn.
Not only will the deal strengthen nestle 's health and...
Generic Lamisil® Tablets and OTC Terbinafine Cream, Approved by the FDA
in Straightfromthedoc, on July 4, 2007
... A product of Novartis , Lamisil® (terbinafine hydrochloride) Tablets is a prescription drug for the treatment of nail fungus infection ( onychomycosis ).
Now, the FDA has approved the first...
Once a Year Pill for Osteoporosis
in Well Woman Blog, on May 6, 2007
...density.
The Clinical Cases and Images Blog states:
The new once-yearly Aclasta manufactured by Novartis has been shown to be as effective as weekly Fosamax in reducing incidence of bone fracture ...
Once-a-Year Osteoporosis Drug Reclast Effectively Reduces Fracture Incidence
in The Biotech Weblog, on May 4, 2007
...d as Reclast ), is an investigational drug in the bisphosphonate drug category, being developed by Novartis Pharmaceuticals Corp., and is still in the approval process through the Food and Drug Admin...
Novartis Acquires Rights to Cytos' Smoking Vaccine
in The Biotech Weblog, on April 26, 2007
...
Novartis AG has acquired worldwide exclusive rights to a novel vaccine candidate against nicotine addiction from Cytos Biotechnology AG for up to 600 million Swiss francs (US$500 million; €366...
Colin Powell at the AMR Research's supply chain executive conference
in Supplychainer, on April 15, 2007
...dent, Supply Chain Operations, Polo Ralph Lauren
- Tom van Laar, Head Global Technical Operations, Novartis Pharma AG
- Jim Waters, Vice President Caterpillar Production System Division, Caterpillar...
FDA Approves Novartis' Hypertension Drug Tekturna
in The Biotech Weblog, on March 8, 2007
... The US FDA has approved Novartis' new hypertension drug, Tekturna (aliskiren), a direct renin inhibitor. A once-daily oral tablet therapy, Tekturna acts by blocking renin, an enzyme responsible...
The Diabetes Genetics Initiative
in The Biotech Weblog, on February 13, 2007
...
The Broad Institute, Lund University and Novartis have announced the completion of a genome-wide map of genes related to type 2 diabetes and other metabolic disorders.
Driven by recent adv...
Liver X Receptor: A Dual Role Glucose Sensor
in Straightfromthedoc, on December 30, 2006
...types, such as the pancreas, activate LXR.
This study, supported by the Genomics Institute of the Novartis Research Foundation was published December 20 in an advanced, online edition of Nature .
...
Top 20 Employers in the Biotech and Pharmaceutical Industries
in The Biotech Weblog, on October 23, 2006
...op 10 in a third tier, with scores of 70 to 79, the survey identifies Johnson & Johnson, Lilly, Novartis, and GlaxoSmithKline.
A detailed report and analysis of the ranking, including the complet...
Sustainability reporting: carrots and sticks
in Sox First, on October 11, 2006
... The previous guidelines have been used by many corporations around the world, including Nike, Gap, Novartis, Microsoft and ABN Amro. Still, questions remain about their effectiveness and whether tr...
Once-Yearly Osteoporosis Drug Aclasta Reduces Bone Fractures
in The Biotech Weblog, on September 25, 2006
...of Aclasta, is also available under the brand name Zometa for use in other indications.
Source: Novartis
...
Cell Therapeutics and Novartis Co-Develop Poliglumex Paclitaxel
in The Biotech Weblog, on September 19, 2006
... Cell Therapeutics, Inc. and Novartis will collaborate to co-develop XYOTAX™ (poliglumex paclitaxel), an investigational agent in Phase III for the treatment of non-small cell lung cancer ...
Merck Develops New Diabetes Treatment
in Daily Diabetic, on August 31, 2006
... mid-October to make a decision on whether to approve Januvia.
Another drug, Galvus (developed by Novartis) is already being geared to compete with Januvia....
Allergy Treatment for Children
in Allergies, on August 30, 2006
Trisha over at Ideas for Women wrote a commentary and some tips for coping with allergies .
For small children, she recommends Zyrtec and Claritin . Depending on the age of your child, Zyrtec comes in syrup , chewable tablets or normal tablets. For Claritin, there's syrup or ta...
Entelos Collaborates With Novartis On In Silico Drug Trials
in The Biotech Weblog, on August 23, 2006
...ion existing products in competitive markets.
Entelos just entered into a research agreement with Novartis AG to predict the effect of Novartis ' drug candidates on " virtual patients &qu...
20 companies changing the world (for the better)
in Audeamus - How dare we..., on July 26, 2006
...asters (Nasdaq: GMCR)
Interface (Nasdaq: IFSIA)
JM Inc. (JM.ST)
Maxwell Technologies (Nasdaq: MXWL)
Novartis AG (NYSE: NVS)
Ormat Technologies (NYSE: ORA)
Philips Electronics NV (NYSE: PHG)
Precious ...
Novartis To Build Cell-Culture Based Flu Vaccines Plant in US
in The Biotech Weblog, on July 19, 2006
... Novartis will build a $600 million plant in the United States to develop flu vaccines using advanced, cell-culture techniques . The facility would be based in holly Springs, North Carolin...
Drug Companies Cashing In On Diabetes
in Daily Diabetic, on June 30, 2006
...Pfizer Inc. plans to debut Exubra, its new inhaled insulin treatment, in July, and Merck & Co., Novartis AG and Eli Lilly and Co. are awaiting FDA approval for new diabetes products that could gen...
Summertime, Fenistil-time
in Allergies, on June 16, 2006
Summer is here! The time of the year we're supposed to spend a lot of time outdoors and enjoy the sun, the warmth, and all the various activities we can do only during summer! Fun, fun, fun!
Unfortunately, not so for my son. The last week, he's been suffering from itchy nose, itchy eyes,...
Novartis Buys Rights to Intecell's Japanese Encephalitis Vaccine Candidate
in The Biotech Weblog, on June 14, 2006
... Novartis is buying rights to Austrian biotech firm Intercell AG 's IC51 experimental vaccine against the tropical disease Japanese encephalitis . IC51 will be an addition to Novartis'...
Novartis Bids for NeuTec, Expands Into Hospital Anti-Infectives
in The Biotech Weblog, on June 8, 2006
...
Novartis is hoping to strengthen its biopharmaceutical portfolio by offering to acquire British firm
NeuTec Pharma plc for $570 million, a 109% premium to the current share price.
Ne...
Novartis Receives $220M Grant To Develop Cell-Culture Derived Flu Vaccine
in The Biotech Weblog, on May 5, 2006
...nt of using chiken eggs.
The US Department of Health and Human Services (HHS) has just awarded Novartis ' new Vaccines and Diagnostics division about $220 million to support the development...
Legislation limits state rights to biotech labeling: nanotech to follow?
in Nanotechbuzz, on April 3, 2006
...s say the bill came about because certain large agriculture and food-production companies - such as Novartis, General Mills and Monsanto - dislike the increasing efforts by activists and others to pas...
The Irritable Bowel Syndrome (IBS): A Market Analysis
in The Biotech Weblog, on March 2, 2006
...prevalence and assuming 50% penetration, 7 (30-day) prescriptions per year and pricing in line with Novartis' tegaserod , IBS could represent a market on par with the current GERD ($15 billion) ...
Novartis Receives European Commission Approval To Acquire Chiron
in The Biotech Weblog, on February 7, 2006
...
Novartis announced yesterday that the European Union antitrust regulators approved of its takeover of Chiron Corp. When I first blogged about the takeover here in this weblog, I thoug...
Novartis Will Not Bid For Berna Biotech
in The Biotech Weblog, on January 10, 2006
...
After much speculations , Novartis finally decides not to bid for Berna Biotech AG , leaving it up for Dutch biotechnology start-up firm, Crucell, to take-over.
"After completion ...
Handelsblatt-Jahrestagung: CIO 2010 - weniger IT, mehr Strategie
in Das CIO Weblog, on January 8, 2006
...sident and CEO, Advanced Micro Devices), Frank Annuscheit (CIO, Commerzbank), Jim Barrington (CIO, Novartis), Daniel Hartert (CIO, Royal Philips Electronics N.V), Dr. Johannes Helbig (Mitglied des Ber...
Will Novartis Outbid Crucell for Berna Biotech?
in The Biotech Weblog, on December 19, 2005
...
Following its announcement of intending a full takeover of Chiron Vaccines , Swiss pharma giant Novartis considers acquiring another Swiss biotech company, Berna Biotech AG , to complement its p...
Serono Hold Talks With Biopharmaceutical Giants For Potential Take-over
in The Biotech Weblog, on November 9, 2005
... talks with four biopharma giants about a potential $15 billion takeover. Interested parties were: Novartis, GlaxoSmithKline, Sanofi- Aventis and Pfizer. Amgen bows out, Roger Perlmutter, vice-...
Novartis Takes Over Chiron Corp
in The Biotech Weblog, on November 7, 2005
... Last week, Swiss pharmaceutical giant Novartis agreed to completely take over American vaccine maker Chiron Corp. Novartis paid $45 a share, shelling out $5.1 billion to acquire the remaining 58%...
Biotech Companies Announcing Public Offering of Common Stocks
in The Biotech Weblog, on September 19, 2005
...nsion and darusentan for the treatment of resistant systolic hypertension. In collaboration with Novartis , Myogen also conducts a target and drug discovery research program for the treatment of ch...
NexMed Licenses Nail Fungus Drug to Novartis
in The Biotech Weblog, on September 16, 2005
...
Novartis AG gets exclusive worldwide rights to NexMed 's proprietary NM100060 nail lacquer treatment for onychomycosis , commonly known as nail fungus. NM100060 is currently in Phase 1...
Novartis Offers $4.5B for Complete Takeover of Chiron
in The Biotech Weblog, on September 1, 2005
... Novartis AG said it's offering $40 a share for the 57.8% it doesn't already own in Chiron . According to Novartis spokesman John Gilardi,
"Novartis believes this will put Chiron i...
New approaches to hypertension in the pipeline
in Straightfromthedoc, on July 23, 2005
...ood pressure. The first of these agents to be introduced on the market is likely to be Aliskiren, a Novartis drug currently in phase III testing. Analysts expect the company to seek regulatory approva...
Cheap Drugs vs. Lost Jobs
in Businesspundit, on January 12, 2004
...India. Now Big Pharma is discovering the same benefits. Pfizer (PFE ), GlaxoSmith-Kline (GSK ), and Novartis (NVS ) are tapping into India's research and manufacturing prowess to cut costs and spe...